14 February 2017

Hans Von den Hoff from the Dept. of Orthodontics and Craniofacial Biology has obtained an Advanced Researcher Grant from the Suisse Osteology Foundation (80.000 CHF).

The grant is intended to study muscle function in the soft palate using electromyography in a rat model for surgical injury of the soft palate. Muscle function will be monitored with telemetric devices implanted in the rats in collaboration with the Donders Institute for Brain, Cognition and Behaviour. This study belongs to his research on cleft palate repair. The study will be carried out by a new PhD candidate from Colombia, Doris Haydee Rosero Salazar.

Related news items


How do we keep new technology affordable to improve the lives of people?

16 May 2019

Improving healthcare by means of new technological developments? We need to change the entire approach for evaluating the true impact , says Maroeska Rovers. By bringing together all stakeholders from the beginning, millions of euros can be saved.

read more

RIMLSpeaks Challenge for change

15 May 2019

The third edition of RIMLSpeaks entitled “Challenge for change" was organized for all our (j)PI’s in Huize Heyendael.

read more

Join the Young Academy of Europe

15 May 2019

The YAE is a pan-European initiative of outstanding young researchers, from all fields, for networking, scientific exchange and science policy.

read more

Dutch Kidney Foundation Innovation grant for Tom Nijenhuis

14 May 2019

Tom Nijenhuis, theme Renal disorders, received this grant for his research project “Salt supplementation in Gitelman syndrome: A simple intervention using an innovative N-of-1 trial approach”.

read more

Algorithm calculates the presence and aggressiveness of prostate tumors

14 May 2019

A computer program that analyzes MRI images can reliably map the presence and even the aggressiveness of a prostate tumor. This is what Radboudumc researchers and international colleagues have published in the scientific journal Investigative Radiology.

read more

Universal tumor BRCA1/2 testing of ovarian cancer

13 May 2019

Marjolijn Ligtenberg, Janet Vos and Nicoline Hoogerbrugge, assessed the feasibility of a workflow for universal tumor DNA BRCA1/2 testing of all newly diagnosed OC patients as prescreen for PARPi treatment and cancer predisposition testing. They have published their findings in the JNCI.

read more